Humana said diluted earnings per share (EPS) for Q3 2024 was $3.98 on a GAAP basis and $4.16 on an Adjusted (non-GAAP) basis, compared with GAAP EPS of $6.71 and Adjusted EPS of $7.78 for 3Q23.

1. 01

   Humana said diluted earnings per share (EPS) for Q3 2024 was $3.98 on a GAAP basis and $4.16 on an Adjusted (non-GAAP) basis, compared with GAAP EPS of $6.71 and Adjusted EPS of $7.78 for 3Q23.

2. 02

   The company reported pretax income of $651 million on a GAAP basis and $679 million on an Adjusted (non-GAAP) basis for Q3 2024. It said 3Q23 were $1,098 million and $1,268 million, respectively.

3. 03

   Humana said its consolidated benefits expense ratio for Q3 2024 was 89.9% on a GAAP basis (3Q23 86.6%) and 89.8% on an Adjusted (non-GAAP) basis (3Q23 86.4%). It also said it is maintaining its FY 2024 Insurance segment benefit ratio at approximately 90%.

4. 04

   Humana said it updated its full-year FY 2024 diluted EPS guidance to at least $12.89 on a GAAP basis and at least $16.00 on an Adjusted (non-GAAP) basis. The company said it now expects 2024 individual Medicare Advantage annual membership growth to be 40,000 higher, to approximately 265,000 (approximately 5%).

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.